English press releases

IFF to Hold Virtual Annual Meeting of Shareholders for 2020 on May 6

NEW YORK–(BUSINESS WIRE)– Regulatory News: IFF (NYSE:IFF) (Euronext Paris: IFF) (TASE: IFF), a leading innovator of taste, scent, and nutrition, announced today that its 2020...

Eurofins Technologies’ Range of Testing Kits for Serology-based Antibody Detection by ELISA in Patients Exposed to COVID-19 now Available to Order Online by Government Approved Clinical Laboratories Globally

LUXEMBOURG–(BUSINESS WIRE)– In a continued effort to help fight the COVID-19 crisis, Eurofins Technologies announces the CE-IVD marking of a first range of testing kits...

Boehringer Ingelheim’s Aservo® EquiHaler® wins Red Dot for outstanding design quality

Boehringer Ingelheim’s Aservo® EquiHaler® wins the Red Dot Award: Product Design 2020 Red Dot has become established internationally as one of the most sought-after seals...

European Commission approves nintedanib for the treatment of systemic sclerosis-associated interstitial lung disease (SSc-ILD)

Approval is based on the SENSCIS® study which showed nintedanib slows the loss of pulmonary function in people living with systemic sclerosis-associated ILD (SSc-ILD)1 Following...

Vertex Announces Innovative Reimbursement Agreement in Switzerland for ORKAMBI® (lumacaftor/ivacaftor) and SYMDEKO® (tezacaftor/ivacaftor and ivacaftor) for Eligible Cystic Fibrosis Patients

Agreement also enables the possibility of rapid patient access to future triple combination regimen (elexacaftor/tezacaftor/ivacaftor and ivacaftor) once approved in Switzerland LONDON–(BUSINESS WIRE)– Vertex Pharmaceuticals...

VFMCRP and Cara Therapeutics announce positive results from global KALM-2 pivotal phase-III trial of KORSUVA™ injection in haemodialysis patients with Pruritus

Statistically significant improvement in primary endpoint of proportion of patients with three point or greater reduction in mean worst itching intensity NRS score vs. placebo...

Alibaba Cloud Joins Technology Committee of the Content Delivery and Security Association (CDSA)

Global media and entertainment industry body elects Alibaba Cloud to advise its Board of Directors Alibaba Cloud, the data intelligence backbone of Alibaba Group, has...

Ipsen Announces Positive Topline Results From Pivotal Phase III CheckMate -9ER Trial Evaluating CABOMETYX® (cabozantinib) in Combination with Opdivo® (nivolumab) in Previously Untreated Advanced Renal Cell Carcinoma

Study met primary endpoint of significantly improving progression-free survival, and secondary endpoints of overall survival and objective response rate vs. sunitinib CABOMETYX in combination with...

Alibaba Challenges Students to Create Solutions for a Post Covid-19 World

GET Network to judge and fund six winning teams from 13 markets HANGZHOU, China–(BUSINESS WIRE)– Innovative students from across 13 markets who want to help...

Sofinnova Partners Announces Third Investment From Its Italian Fund

This investment brings the total financing by Sofinnova Partners to €25 million over the past six months MILAN–(BUSINESS WIRE)– Sofinnova Partners, a leading European life...

ENA Investment Capital Announcement Regarding Ontex Shareholding

LONDON–(BUSINESS WIRE)– ENA Investment Capital (“ENA”), a long-term, value orientated investment firm, today notified Ontex Group NV (“Ontex” or “the Company”) and the Belgian Financial...

Ant Financial Opens Consortium Blockchain Platform to SMEs and Developers

HANGZHOU, China–(BUSINESS WIRE)– Ant Financial today announced the launch of OpenChain, a blockchain platform that enables small and micro enterprises (SMEs) and developers to tap...

ServiceNow Makes No Layoff Pledge for 2020

Company plans to keep hiring in 2020; summer college intern program goes digital SANTA CLARA, Calif.–(BUSINESS WIRE)– ServiceNow (NYSE: NOW), the leading digital workflow company...

Samsung Bioepis Announces US Launch of ONTRUZANT® (trastuzumab-dttb) for Early and Metastatic HER2-overexpressing Breast Cancer and Metastatic Gastric Cancer

ONTRUZANT® is Samsung Bioepis’ first oncology biosimilar available in the United States INCHEON, Korea–(BUSINESS WIRE)– Samsung Bioepis Co., Ltd. announced today that ONTRUZANT® (trastuzumab-dttb), a...

Sisvel Announces the Launch of its MIOTY LPWAN Licensing Program

LUXEMBOURG–(BUSINESS WIRE)– Sisvel International S.A. (“Sisvel”) announced today the launch of its “MIOTY” Licensing Platform, a new joint patent licensing effort for the MIOTY technology....